Coagulation dynamics after hemodilution with polyhemoglobin
- PMID: 1381112
Coagulation dynamics after hemodilution with polyhemoglobin
Abstract
The effect of polyhemoglobin solution (PHS), a candidate erythrocyte cell substitute, on blood coagulation, was investigated. Whole blood samples from six male Sprague-Dawley rats were diluted in vitro 3:1, 1:1 and 1:3 with normal saline solution, stroma-free hemoglobin (SFH) (7 grams of hemoglobin per deciliter), PHS (14 grams of hemoglobin per deciliter) or 5 percent bovine albumin (ALB) and tested with a thrombelastograph (TEG) for effects of hemodilution on coagulation. For in vivo tests, 24 rats were randomly divided into four groups of six each and 50 percent of the estimated blood volume was replaced with SFH, PHS, ALB or 6 percent hydroxyethyl starch. Blood samples collected before and after the hemodilution were tested with a TEG. The TEG parameters (r, k, Ma, and fi) were determined and analyzed statistically. At 50 percent in vitro or in vivo hemodilution, PHS did not cause significant alteration (p greater than 0.05) in initial coagulation mechanism, while SFH slightly, but significantly (p less than 0.05), accelerated coagulation. Tensile strength of formed clot (Ma) did decrease after hemodilution with PHS (p less than 0.05), but the effect was attributable to dilutional effect. At moderate hemodilution (50 percent), PHS does not seem to cause undue coagulopathy in this rat model.
Similar articles
-
[Thrombelastographic coagulation analysis following in vitro and in vivo haemodilution with hydroxyethyl starch (HES)].Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 May;37(5):258-66. doi: 10.1055/s-2002-30129. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002. PMID: 12015682 German.
-
Does OxyVita, a new-generation hemoglobin-based oxygen carrier, or oxyglobin acutely interfere with coagulation compared with normal saline or 6% hetastarch? An ex vivo thromboelastography study.J Cardiothorac Vasc Anesth. 2008 Feb;22(1):34-9. doi: 10.1053/j.jvca.2007.02.016. Epub 2007 May 24. J Cardiothorac Vasc Anesth. 2008. PMID: 18249328
-
Does Hextend impair coagulation compared to 6% hetastarch? An ex vivo thromboelastography study.Am J Ther. 2008 May-Jun;15(3):225-30. doi: 10.1097/MJT.0b013e31815aec71. Am J Ther. 2008. PMID: 18496260
-
Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.Acta Anaesthesiol Scand. 2005 Mar;49(3):373-8. doi: 10.1111/j.1399-6576.2005.00619.x. Acta Anaesthesiol Scand. 2005. PMID: 15752404 Clinical Trial.
-
Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits.J Trauma. 2008 May;64(5):1218-28; discussion 1228-9. doi: 10.1097/TA.0b013e31816c5c6c. J Trauma. 2008. PMID: 18469644
Cited by
-
How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.Int J Mol Sci. 2023 Oct 4;24(19):14902. doi: 10.3390/ijms241914902. Int J Mol Sci. 2023. PMID: 37834350 Free PMC article. Review.
-
Critically ill cancer patients are not consistently hypercoagulable after craniotomy.Neurocrit Care. 2007;7(3):211-6. doi: 10.1007/s12028-007-0064-2. Neurocrit Care. 2007. PMID: 17968522 Clinical Trial.
-
Effects of hemoglobin-based oxygen carriers on blood coagulation.J Funct Biomater. 2014 Dec 12;5(4):288-95. doi: 10.3390/jfb5040288. J Funct Biomater. 2014. PMID: 25514567 Free PMC article. Review.
-
Hemodilution is not critical in the pathogenesis of the acute coagulopathy of trauma.J Surg Res. 2012 Mar;173(1):26-30. doi: 10.1016/j.jss.2011.04.047. Epub 2011 May 19. J Surg Res. 2012. PMID: 21696767 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous